Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marel Director's Dealing 2020

Oct 27, 2020

2191_rns_2020-10-27_5df98c1f-e1af-4b58-bebe-4a70e75c9c83.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEDLABAT 1. SLANDS

FJÁRMÁLA EFTIRLIT

Viðskipti fruminnherja/

Transaction of primary insider

Vinsamlegast tilkynnist til [email protected]/

Please send the form to [email protected]

Auðkenni útgefanda/Trade ticker: MAREL

Nafn útgefanda/Issuer: Marel hf.

Dagsetning tilkynningar/Date of announcement: 27.10.2020

Nafn fruminnherja/Name primary insider: Árni Oddur Þórðarson

Tengsl fruminnherja við útgefanda/Insider's relation with the issuer: Forstjóri / CEO

Dagsetning viðskipta/Date of transaction: 27.10.2020

Tímasetning viðskipta/Time of transaction: 0

Tegund fjármálagernings/Type of financial instrument: Hlutabréf / Equities

Kaup eða sala/Buy or Sell: Kaup

Fjöldi hluta/Number of shares: 278.009

Verð pr. Hlut/Price per share: EUR 2,349

Fjöldi hluta í eigu fruminnherja eftir viðskipti/Primary insider's holdings after the transaction: 342.643

Fjöldi hluta sem fruminnherji á kauprétt að/Primary insider's option holdings after the transaction: 1.952.000

Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties' holdings after the transaction: 67.235

Dagsetning lokauppgjørs/Date of settlement: 0

¹ Fruminnherji á jafnframt 17,9% hlut í Eyri Invest hf. sem er stærsti hluthafi Marel hf. / Primary insider holds 17.9% of total share capital of Eyrir Invest hf., which is Marel's largest shareholder.


FJÁRMÁLA EFTIRLIT

Athugasemdir/Comments:

Viðskiptin eru til að mæta skilyrðum um framkvæmd kaupréttarsamninga. Kaupréttirnir voru veittir árin 2016 og 2017 á grundvelli starfskjarastefnu félagsins eins og hún var samþykkt af aðalfundi á hverjum tíma. Móttekin bréf nema mismun á vegnu meðalkaupverði kaupréttanna sem var 2,349 evrur á hlut og dagslokagengi á Euronext Amsterdam þann 26.10.2020, hvort tveggja margfaldað með fjölda nýttra kauprétta sem voru 888.000, að frádregnum sköttum.

Transaction to fulfill obligations of stock option agreements. The stock options were granted in the years 2016 and 2017 in accordance with the Company's Remuneration Policy as approved at the Company's respective AGMs. Received shares equal the difference of the weighted average exercise price of the stock options (EUR 2.349 per share) and closing price on Euronext Amsterdam on 26 October 2020, both numbers multiplied with the number of exercised stock options which were 888,000, less taxes.

2